1. Home
  2. MVF vs PRME Comparison

MVF vs PRME Comparison

Compare MVF & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MVF
  • PRME
  • Stock Information
  • Founded
  • MVF 1988
  • PRME 2019
  • Country
  • MVF United States
  • PRME United States
  • Employees
  • MVF N/A
  • PRME N/A
  • Industry
  • MVF Investment Bankers/Brokers/Service
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • MVF Finance
  • PRME Health Care
  • Exchange
  • MVF Nasdaq
  • PRME Nasdaq
  • Market Cap
  • MVF 450.3M
  • PRME 424.9M
  • IPO Year
  • MVF N/A
  • PRME 2022
  • Fundamental
  • Price
  • MVF $7.30
  • PRME $3.35
  • Analyst Decision
  • MVF
  • PRME Strong Buy
  • Analyst Count
  • MVF 0
  • PRME 8
  • Target Price
  • MVF N/A
  • PRME $13.86
  • AVG Volume (30 Days)
  • MVF 162.8K
  • PRME 1.0M
  • Earning Date
  • MVF 01-01-0001
  • PRME 11-12-2024
  • Dividend Yield
  • MVF 4.11%
  • PRME N/A
  • EPS Growth
  • MVF N/A
  • PRME N/A
  • EPS
  • MVF N/A
  • PRME N/A
  • Revenue
  • MVF N/A
  • PRME $800,000.00
  • Revenue This Year
  • MVF N/A
  • PRME N/A
  • Revenue Next Year
  • MVF N/A
  • PRME $21.23
  • P/E Ratio
  • MVF N/A
  • PRME N/A
  • Revenue Growth
  • MVF N/A
  • PRME N/A
  • 52 Week Low
  • MVF $5.85
  • PRME $3.28
  • 52 Week High
  • MVF $7.19
  • PRME $9.86
  • Technical
  • Relative Strength Index (RSI)
  • MVF 44.57
  • PRME 36.39
  • Support Level
  • MVF $7.28
  • PRME $4.03
  • Resistance Level
  • MVF $7.38
  • PRME $4.49
  • Average True Range (ATR)
  • MVF 0.07
  • PRME 0.32
  • MACD
  • MVF 0.01
  • PRME -0.08
  • Stochastic Oscillator
  • MVF 52.38
  • PRME 3.18

About MVF Blackrock MuniVest Fund Inc.

Blackrock Munivest Fund Inc is an investment management firm. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company invests in various sectors such as Health; Transportation; Utilities; Education; Tobacco; Housing and others.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: